# Gene Therapy for X-linked Chronic Granulomatous Disease (X-CGD)

> **NCT01855685** · PHASE1,PHASE2 · TERMINATED · sponsor: **Genethon** · enrollment: 3 (actual)

## Conditions studied

- X-Linked Chronic Granulomatous Disease

## Interventions

- **GENETIC:** X vivo gene therapy

## Key facts

- **NCT ID:** NCT01855685
- **Lead sponsor:** Genethon
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-06-24
- **Primary completion:** 2021-06-04
- **Final completion:** 2025-10-17
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Last patient withdrawed from the study.
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01855685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01855685, "Gene Therapy for X-linked Chronic Granulomatous Disease (X-CGD)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01855685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*